Sun Pharma to launch complete range of generic anti-epilepsy drug

The drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solution (10 mg/ml) and injectable (10 mg/ml) will be available in the market over the next few weeks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aKlBIo
via IFTTT